Rigorous Cost Management in the Construction Business
First written in FY2018. 10 of 30 entries say "Advanced", first in FY2019-Q1. Latest entry: 2026-11-16.
6 other companies' latest entry also says "Other".
- FY2026AdvancedAnnual report
「In the construction-related business, continue to enforce cost controls capable of withstanding intense price competition, while increasing the proportion of orders from fields outside the core medical sector and expanding into diverse fields capable of withstanding changes in the business environment」
While continuing cost controls, order intake and net sales declined, but operating profit rose 13.7% year on year to ¥428 million. - FY2026-H1Profit improvement despite declines in orders and salesAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, saw a decline in the number of new-build and renovation projects. Order intake fell 11.4% year on year to ¥1,544 million and net sales fell 18.0% to ¥1,001 million, while operating profit rose 42.4% to ¥186 million.」
In the construction-related business, order intake and net sales declined because of fewer projects, while operating profit exceeded the previous year's level. - FY2025Lower sales and broadly flat profit despite higher order intakeAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, benefited from a slight recovery in new-build and renovation projects and the effect of higher construction unit prices. Order intake rose 11.6% year on year to ¥2,874 million, while net sales fell 2.9% to ¥2,732 million and operating profit rose 0.2% to ¥376 million.」
In the construction-related business, order intake increased, while net sales declined and operating profit remained broadly unchanged from the previous fiscal year. - FY2025-H1Lower sales and profit despite higher order intake in the construction businessAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, saw an increase in the number of new-build and renovation projects. Order intake rose 12.9% year on year to ¥1,742 million, but net sales fell 22.5% to ¥1,220 million and operating profit fell 27.7% to ¥130 million.」
In the construction-related business, the number of new-build and renovation projects increased and order intake grew, but net sales and operating profit fell below the previous year's levels. - FY2024Higher sales and profit due to a recovery in projects and higher construction unit pricesAnnual report
「The number of new-build and renovation projects recovered slightly, and higher construction unit prices also contributed. As a result, order intake fell 3.4% year on year to ¥2,575 million, while net sales rose 1.4% to ¥2,815 million and operating profit rose 16.4% to ¥376 million.」
In the construction business, order intake declined, but net sales and operating profit increased because of a slight recovery in the number of projects and the effect of higher construction unit prices. - FY2024-Q3Higher sales and profit amid fewer projects and price competitionAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, faced a decline in the number of new-build and renovation projects and intense price competition with competitors and other industry peers. As a result, order intake fell 6.8% year on year to ¥1,978 million, while net sales rose 9.0% to ¥2,282 million and operating profit rose 22.1% to ¥274 million.」
In the construction-related business, order intake declined because of fewer projects and intense price competition, while net sales and operating profit exceeded the previous year's levels. - FY2024-Q1Lower profit due to surging raw material pricesAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake up 79.6% year on year to ¥912 million and net sales up 2.7% to ¥725 million as construction progressed as planned. However, operating profit fell 91.2% to ¥5 million because of surging raw material prices and other factors.」
In the construction-related business, order intake and net sales increased and construction progressed as planned, but operating profit fell 91.2% year on year because of surging raw material prices. - FY2023Full-year decline in sales and profit due to fewer projects and price competitionAnnual report
「The number of new-build and renovation projects declined, and intense price competition among general contractors resulted in order intake falling 20% year on year to ¥2,666 million, net sales falling 14.3% to ¥2,775 million, and operating profit falling 25.7% to ¥323 million.」
In the construction-related business, the decline in the number of projects and intense price competition caused order intake, net sales and operating profit to fall below the previous fiscal year's levels. - FY2023-Q3Lower sales but higher profit amid fewer projects and price competitionAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, faced a decline in the number of new-build and renovation projects and intense price competition among general contractors. As a result, order intake fell 18.1% year on year to ¥2,122 million and net sales fell 8.5% to ¥2,093 million, while operating profit rose 3.7% to ¥224 million.」
In the construction-related business, order intake and net sales declined because of fewer projects and price competition among general contractors, while operating profit exceeded the previous year's level. - FY2023-Q2Lower sales and profit amid fewer projects and intensified price competitionAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, faced a decline in the number of new-build and renovation projects and intense price competition. As a result, order intake fell 32.4% year on year to ¥1,048 million, net sales fell 10.3% to ¥1,320 million, and operating profit fell 26.6% to ¥132 million.」
In the construction-related business, the decline in the number of new-build and renovation projects and intense price competition caused order intake, net sales and operating profit to fall below the previous year's levels. - FY2023-Q1Slight sales growth and lower profit amid intensified competition for ordersAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake down 32.8% year on year at ¥508 million because of delays in private-sector construction investment orders and intensified competition for orders. Net sales rose 2.3% to ¥705 million, but operating profit fell 14.7% to ¥60 million.」
In the construction-related business, order intake declined because of delays in private-sector construction investment orders and intensified competition for orders. Although net sales increased, operating profit fell below the previous year's level. - FY2022Construction delays caused by COVID-19 and lower profitAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, pursued sales activities based on the Group's competitive advantage in the industry, resulting in order intake falling 1.2% from the previous fiscal year to ¥3,332 million. However, construction delays caused by COVID-19 led to net sales falling 8.0% to ¥3,240 million, while operating profit fell 16.7% to ¥435 million.」
In the construction business, the decline in order intake was limited, but net sales and operating profit fell because of construction delays caused by COVID-19. - FY2022-Q3Continued decline in profit due to schedule delaysAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, pursued sales activities based on the Group's competitive advantage in the industry. As a result, order intake fell 9.6% year on year to ¥2,591 million. Net sales fell 13.3% to ¥2,289 million, partly because of schedule delays, while operating profit fell 40.0% to ¥216 million.」
Order intake, net sales and operating profit fell below the previous year's levels, and the impact of schedule delays on sales and profit continued. - FY2022-Q2Decline in orders, sales and profitAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake down 29.3% year on year at ¥1,549 million, net sales down 13.1% at ¥1,472 million, and operating profit down 8.1% at ¥180 million because of delays in private-sector construction investment orders and intensified competition for orders.」
In the construction-related business, delays in private-sector construction investment orders and intensified competition for orders caused order intake, net sales and operating profit to fall below the previous year's levels. - FY2022-Q1Profit growth through cost reductions despite lower orders and salesAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake down 35.1% year on year at ¥755 million and net sales down 16.0% at ¥689 million because of delays in private-sector construction investment orders and intensified competition for orders. However, innovative cost-reduction measures proved effective, resulting in operating profit rising 3.8% to ¥70 million.」
In the construction-related business, order intake and net sales declined, but operating profit exceeded the previous year's level because of innovative cost-reduction measures. - FY2021Full-year profit decline due to project delaysAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, pursued sales activities based on the Group's competitive advantage in the industry, resulting in order intake rising 1.8% from the previous fiscal year to ¥3,372 million. However, net sales fell 24.5% to ¥3,522 million because of construction delays caused by COVID-19. Although profitability had improved considerably through efficiency gains from thorough cost control and workload leveling, operating profit fell 30.8% to ¥522 million because of the decline in sales caused by the construction delays.」
While the company stated that profitability had improved through cost control and workload leveling, construction delays caused by COVID-19 were reflected in full-year results as a 24.5% decline in net sales and a 30.8% decline in operating profit. - FY2021-Q3Continued decline in profit due to schedule delaysAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, pursued sales activities based on the Group's competitive advantage in the industry. As a result, order intake rose 5.7% year on year to ¥2,866 million. Net sales fell 26.8% to ¥2,640 million, partly because of schedule delays, while operating profit fell 37.0% to ¥360 million.」
In the construction-related business, order intake increased, but net sales and operating profit fell below the previous year's levels because of schedule delays. - FY2021-Q2Continued decline in profit due to schedule delaysAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, pursued sales activities based on the Group's competitive advantage in the industry. As a result, order intake rose 12.6% year on year to ¥2,191 million. Net sales fell 30.4% to ¥1,694 million, partly because of schedule delays and the limited number of large projects completed during the period, while operating profit fell 47.9% to ¥196 million.」
In the construction business, order intake increased, but net sales and operating profit fell below the previous year's levels because of schedule delays and the lower number of large projects completed. - FY2021-Q1Lower profit due to delays in project completionAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake up 20.6% year on year at ¥1,164 million, supported by the Group's competitive advantage in the industry. Net sales fell 37.0% to ¥821 million, affected by delays in project completion and the limited number of large projects completed in the same period of the previous year, while operating profit fell 64.5% to ¥68 million.」
In the construction business, order intake increased, but net sales and operating profit fell below the previous year's levels because of delays in project completion and other factors. - FY2020AdvancedAnnual report
「In terms of profit, profitability had improved considerably through efficiency gains from thorough cost control and workload leveling. In addition, the ability to procure lead, steel and other construction materials at relatively low prices contributed to operating profit rising 40.2% from the previous fiscal year to ¥754 million.」
The construction-related business improved profitability through cost control, workload leveling and materials procurement, recording operating profit of ¥754 million. - FY2020-Q3AdvancedAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake up 22.2% year on year at ¥2,712 million and net sales up 27.8% at ¥3,606 million, supported by the Group's competitive advantage in the industry. Profitability improved through thorough cost control and workload leveling, resulting in operating profit rising 80.2% to ¥572 million.」
The construction-related business continued cost control and workload leveling, recording operating profit of ¥572 million as a result of improved profitability. - FY2020-Q2AdvancedAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake up 15.6% year on year at ¥1,946 million and net sales up 25.4% at ¥2,436 million, supported by the Group's competitive advantage in the industry. Profitability improved through thorough cost control and workload leveling, resulting in operating profit rising 65.1% to ¥376 million.」
The construction-related business advanced thorough cost control and workload leveling, improving profitability and recording operating profit of ¥376 million. - FY2020-Q1AdvancedAnnual report
「Profitability improved through thorough cost control and workload leveling, resulting in operating profit rising 51.2% to ¥192 million.」
The construction-related business improved profitability through thorough cost control and workload leveling, recording operating profit of ¥192 million. - FY2019AdvancedAnnual report
「In terms of profit, profitability had improved considerably through thorough cost control and efficiency gains from workload leveling, but operating profit fell 0.1% year on year to ¥537 million because of higher labor costs and surging prices for steel and other materials.」
The company continued to improve profitability through cost control and workload leveling, recording operating profit of ¥537 million in the construction-related business. - FY2019-Q3AdvancedAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake of ¥2,220 million and net sales of ¥2,822 million, supported by the Group's competitive advantage in the industry. Profitability improved as a result of lower variable costs and workload leveling, resulting in operating profit of ¥317 million.」
The construction-related business reduced variable costs and advanced workload leveling, improving profitability and resulting in operating profit of ¥317 million. - FY2019-Q2AdvancedAnnual report
「This business, which is primarily engaged in radiation protection and electromagnetic shielding works for medical facilities, recorded order intake of ¥1,683 million and net sales of ¥1,942 million, supported by the Group's competitive advantage in the industry. Profitability improved through thorough cost control and workload leveling, resulting in operating profit of ¥228 million.」
The company explained that it continued thorough cost control and workload leveling in the construction-related business, recording operating profit of ¥228 million and improving profitability. - FY2019-Q1AdvancedAnnual report
「Profitability improved through thorough cost control and workload leveling, resulting in operating profit of ¥127 million.」
In addition to cost control, workload leveling was implemented, improving profitability in the construction-related business and resulting in operating profit of ¥127 million. - FY2018First statedAnnual report
「Continue to enforce cost controls capable of withstanding intense price competition」
The company indicated that it will continue cost controls as a measure to address price competition.